Operating Margin

With a massive French state-guaranteed financing, Eutelsat is funding a new fleet of 340 Airbus satellites to secure OneWeb's future in the LEO race.

South Korea's Hugel shatters sales records with a 105% surge in the Americas, signaling a major power shift in the global medical aesthetics market.

With a 135% revenue surge and a key FDA submission for its kidney transplant drug, Hansa Biopharma is poised for a pivotal year of expansion.

After a challenging 2025, Lennox sets the stage for its March 4 Investor Day, where it will reveal new long-term growth targets to a watchful market.

Top broker NTG partners with Epay Manager, signaling a major move toward AI-driven automation and faster payments for its 80,000+ carrier network.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

Fresh off a strategic rebrand and a record-breaking year, Potomac Bancshares is courting investors and cementing its role as a Mid-Atlantic banking leader.

Celularity Inc. has secured a $12.2M cash injection by selling tax losses, a move set to accelerate its cutting-edge longevity and regenerative medicine pipeline.

After a stellar 2025, Corpay is hitting the road for key investor conferences. Can it convince the market its impressive growth is just the beginning?

The BDC generated a robust 12.52% yield, but a $7.2M unrealized loss in equities pulled down its net asset value, painting a complex picture.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

Real estate giant KDC is pivoting to power the AI boom, hiring an industry expert to scale its national data center platform amid explosive demand.

A national report card gives the U.S. a 'B' on rare disease policy, but stark state-by-state disparities leave millions vulnerable to financial ruin.

A spike in layoffs to 14-year highs clashes with extreme investor optimism, raising fears of a major market correction on the horizon for 2026.

The nation's top IV therapy franchise reports record growth, but its expansion highlights a booming wellness industry navigating a complex regulatory landscape.

Ambience Healthcare appoints Mike Valli as CRO/CVO, signaling a bold new strategy to prove AI's ROI by tackling clinician burnout and revenue leakage.

Waters finalized its $18.8B merger with BD's units, doubling its size. But investor concerns over near-term performance sent shares tumbling.

Bionano's 2026 virtual event will showcase how Optical Genome Mapping is revolutionizing cancer and genetic disease research and paving a path to clinical use.

Activist investor Impactive Capital nominates four directors to the WEX board, citing years of underperformance and demanding a strategic overhaul.

As ReNew prepares its Q3 FY26 report, all eyes are on the energy giant. Will its performance validate India's green transition and its own manufacturing bet?